Q/C Technologies Inc (QCLS)

$3.81 -0.08 (-2.06%)
Market Cap 16.21M
Revenue (ttm) 0.00
Net Income (ttm) -11.63M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 155,900
Avg Vol 493,650
Day's Range N/A - N/A
Shares Out 4.17M
Stochastic %K 26%
Beta 2.17
Analysts Strong Buy
Price Target N/A

Company Profile

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog derivative of cannabi...

Industry: Computer Hardware
Sector: Technology
Phone: 856 848 8698
Address:
1185 Avenue of the Americas, Suite 249, New York, United States
NiceW2Kid
NiceW2Kid Jun. 24 at 9:49 PM
$QCLS interpretation? I shut down your backpedal with a screenshot What a goddamn fucking piece of shit this stock is that two bulls are arguing about something I mean how the motherfuck cocksuck much longer is these dicksucks going to make us wait???
2 · Reply
NiceW2Kid
NiceW2Kid Jun. 24 at 8:14 PM
$QCLS you're lobbing random bullshit Your prediction about April was 100% wrong and when you tried to backpedal it to regarding short interest I proved you wrong with info anyone can get from nasdaq.com
1 · Reply
henryqoo5779
henryqoo5779 Jun. 24 at 7:46 PM
$QCLS $SPCX suprise me plz
0 · Reply
KKEE122
KKEE122 Jun. 24 at 7:44 PM
$QCLS $SPCX Remember what I mentioned about this stock
0 · Reply
KKEE122
KKEE122 Jun. 24 at 7:21 PM
$QCLS I am watching the World Cup
0 · Reply
KKEE122
KKEE122 Jun. 24 at 7:16 PM
$QCLS Reaching 3.7 is completely natural and genuinely beautiful. This is exactly my entry point now. I’ve already clearly outlined the timeframe and targets for you previously — that’s all we need
0 · Reply
TakingHearts90
TakingHearts90 Jun. 24 at 6:53 PM
$QCLS @KKEE122 is to silent… Abort mission! We are going fishing.
0 · Reply
OnlyFibs
OnlyFibs Jun. 24 at 1:06 AM
Is the market sleeping on $QCLS? 💡 With exclusive global rights to LightSolver’s LPU technology, they’re aiming to disrupt traditional crypto mining with laser-speed, energy-efficient processing. It’s a high-risk "show me" story, but the tech—operating entirely on light—is legitimate deep-tech territory. Patience is the ultimate edge while the company scales this dual-model shift. #QCLS #DeepTech #CryptoMining #hovdid 🐂 Bull Level: A clean hold above $4.00 signals institutional interest is returning. 🐻 Bear Level: Watch $3.75 as the primary pivot; if it snaps, the technical breakdown likely deepens.
0 · Reply
Jj1369
Jj1369 Jun. 23 at 9:02 PM
$QCLS shkreli is a scammer known for pumping stocks he has a position in. Fully expect another large pump here before this tails off into oblivion again. Techinicals are solid. No news since March they gotta have something brewing
0 · Reply
extrodyne
extrodyne Jun. 23 at 7:42 PM
$QCLS "QCLS said Martin Shkreli will add industry connections, early-stage growth expertise, and financial innovation insight as it scales its next-gen computing platform." Yes, yes. A felon advisor. Good strategy.
0 · Reply
Latest News on QCLS
Q/C Technologies Quarterly report: Q1 2026

May 15, 2026, 7:00 AM EDT - 5 weeks ago

Q/C Technologies Quarterly report: Q1 2026

Q/C Technologies Annual report: Q4 2025

Apr 15, 2026, 7:00 AM EDT - 2 months ago

Q/C Technologies Annual report: Q4 2025

Q/C Technologies launches optical processing unit initiative

2026-03-18T13:20:54.000Z - 3 months ago

Q/C Technologies launches optical processing unit initiative

Q/C Technologies Launches Optical Processing Unit (OPU) Initiative to Develop Proprietary Silicon Photonic Computing Architecture for AI Inference

Mar 18, 2026, 9:15 AM EDT - 3 months ago

Q/C Technologies Launches Optical Processing Unit (OPU) Initiative to Develop Proprietary Silicon Photonic Computing Architecture for AI Inference

Q/C Technologies files $100M mixed securities shelf

2026-02-11T22:20:14.000Z - 4 months ago

Q/C Technologies files $100M mixed securities shelf

Q/C Technologies Registration statement: Registration Filing

Feb 11, 2026, 7:00 AM EST - 4 months ago

Q/C Technologies Registration statement: Registration Filing

Q/C Technologies appoints Voss to Board of Directors

2026-01-20T14:25:11.000Z - 5 months ago

Q/C Technologies appoints Voss to Board of Directors

Q/C Technologies Appoints AI Systems Leader Chelsea Voss to Board of Directors

Jan 20, 2026, 9:15 AM EST - 5 months ago

Q/C Technologies Appoints AI Systems Leader Chelsea Voss to Board of Directors

Q/C Technologies Inc trading resumes

2025-12-09T14:40:42.000Z - 7 months ago

Q/C Technologies Inc trading resumes

Q/C Technologies Inc trading halted, volatility trading pause

2025-12-09T14:35:17.000Z - 7 months ago

Q/C Technologies Inc trading halted, volatility trading pause

Q/C Technologies appoints Martin Shkreli as senior advisor

2025-12-09T14:20:44.000Z - 7 months ago

Q/C Technologies appoints Martin Shkreli as senior advisor

Quantum-Class Computing Developer Q/C Technologies Welcomes Strategic Advisor Martin Shkreli

Dec 9, 2025, 9:15 AM EST - 7 months ago

Quantum-Class Computing Developer Q/C Technologies Welcomes Strategic Advisor Martin Shkreli

Martin Shkreli touts QCLS stock as a long idea after a “bad call” on CAPR

Dec 4, 2025, 12:05 PM EST - 7 months ago

Martin Shkreli touts QCLS stock as a long idea after a “bad call” on CAPR

Q/C Technologies Quarterly report: Q3 2025

Nov 19, 2025, 7:00 AM EST - 7 months ago

Q/C Technologies Quarterly report: Q3 2025

Q/C Technologies enters collaboration with LightSolver

2025-10-30T13:27:23.000Z - 8 months ago

Q/C Technologies enters collaboration with LightSolver

Q/C Technologies Introduces Proprietary qc-LPU100™ Brand of Quantum-Class Laser Processing Units

Oct 30, 2025, 9:15 AM EDT - 8 months ago

Q/C Technologies Introduces Proprietary qc-LPU100™ Brand of Quantum-Class Laser Processing Units

Q/C Technologies Proxy statement: Proxy Filing

Oct 20, 2025, 8:00 AM EDT - 8 months ago

Q/C Technologies Proxy statement: Proxy Filing

Q/C Technologies appoints Steven Frankel as senior quantum advisor

2025-10-16T13:25:30.000Z - 8 months ago

Q/C Technologies appoints Steven Frankel as senior quantum advisor

Q/C Technologies Appoints Technion Professor Dr. Steven Frankel as Senior Quantum Advisor to Advance Photonic and Quantum-Class Computing Initiatives

Oct 16, 2025, 9:15 AM EDT - 8 months ago

Q/C Technologies Appoints Technion Professor Dr. Steven Frankel as Senior Quantum Advisor to Advance Photonic and Quantum-Class Computing Initiatives

Q/C Technologies Proxy statement: Proxy Filing

Oct 10, 2025, 8:00 AM EDT - 9 months ago

Q/C Technologies Proxy statement: Proxy Filing

Q/C Technologies files to sell 6.51M shares of common stock for holders

2025-10-03T21:35:06.000Z - 9 months ago

Q/C Technologies files to sell 6.51M shares of common stock for holders

Q/C Technologies Registration statement: Registration Filing

Oct 3, 2025, 8:00 AM EDT - 9 months ago

Q/C Technologies Registration statement: Registration Filing

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS”

Sep 25, 2025, 9:15 AM EDT - 9 months ago

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS”

TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing

Sep 24, 2025, 9:15 AM EDT - 9 months ago

TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing

TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

Sep 17, 2025, 9:24 AM EDT - 10 months ago

TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025, 9:15 AM EDT - 10 months ago

TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

TNF Pharmaceuticals Announces Closing of $7 Million Private Placement

Sep 4, 2025, 9:15 AM EDT - 10 months ago

TNF Pharmaceuticals Announces Closing of $7 Million Private Placement

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

Sep 2, 2025, 9:20 AM EDT - 10 months ago

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

PMCB

TNF Pharmaceuticals Secures Exclusive Global Rights to Innovative Light Speed Computing Accelerator for Use in Cryptocurrency Applications

Sep 2, 2025, 9:15 AM EDT - 10 months ago

TNF Pharmaceuticals Secures Exclusive Global Rights to Innovative Light Speed Computing Accelerator for Use in Cryptocurrency Applications

TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance

Aug 28, 2025, 9:15 AM EDT - 10 months ago

TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance

TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation

Aug 19, 2025, 5:20 PM EDT - 11 months ago

TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation

Q/C Technologies Quarterly report: Q2 2025

Aug 19, 2025, 8:00 AM EDT - 11 months ago

Q/C Technologies Quarterly report: Q2 2025

TNF Pharmaceuticals Collaborates with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Autoinflammatory Disease

Jun 24, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Collaborates with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Autoinflammatory Disease

Q/C Technologies Proxy statement: Proxy Filing

May 19, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Proxy statement: Proxy Filing

Q/C Technologies Quarterly report: Q1 2025

May 15, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Quarterly report: Q1 2025

Q/C Technologies Proxy statement: Proxy Filing

May 9, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Proxy statement: Proxy Filing

TNF Pharmaceuticals and Renova Health Report Positive Results in Identifying Targets for Treating TNF-Driven Inflammation in Patients Receiving GLP-1 Agonists

May 8, 2025, 9:20 AM EDT - 1 year ago

TNF Pharmaceuticals and Renova Health Report Positive Results in Identifying Targets for Treating TNF-Driven Inflammation in Patients Receiving GLP-1 Agonists

TNF Pharmaceuticals and Renova Health Utilize AI to Accelerate Drug Development

Apr 22, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals and Renova Health Utilize AI to Accelerate Drug Development

Q/C Technologies Proxy statement: Proxy Filing

Apr 21, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Proxy statement: Proxy Filing

TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha Inhibitor Isomyosamine at British Geriatrics Society's Spring Meeting 2025

Apr 16, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha Inhibitor Isomyosamine at British Geriatrics Society's Spring Meeting 2025

Q/C Technologies Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Proxy statement: Proxy Filing

Q/C Technologies Annual report: Q4 2024

Apr 11, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Annual report: Q4 2024

TNF Pharmaceuticals Delivers Podium Presentation of Novel Oral TNF-Alpha Inhibitor at Premier International Conference on Frailty and Sarcopenia

Mar 17, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Delivers Podium Presentation of Novel Oral TNF-Alpha Inhibitor at Premier International Conference on Frailty and Sarcopenia

TNF Pharmaceuticals to Host Investor Conference Call and Webcast Featuring Clinical Scientific Updates on Thursday, March 6, 2025

Mar 5, 2025, 9:00 AM EST - 1 year ago

TNF Pharmaceuticals to Host Investor Conference Call and Webcast Featuring Clinical Scientific Updates on Thursday, March 6, 2025

TNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha Inhibitor

Feb 25, 2025, 9:20 AM EST - 1 year ago

TNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha Inhibitor

TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment

Jan 29, 2025, 9:15 AM EST - 1 year ago

TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment

TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion

Jan 15, 2025, 9:15 AM EST - 1 year ago

TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs

Dec 19, 2024, 9:15 AM EST - 1 year ago

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs

TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference

Dec 9, 2024, 9:00 AM EST - 1 year ago

TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference

Q/C Technologies Quarterly report: Q3 2024

Nov 14, 2024, 7:00 AM EST - 1 year ago

Q/C Technologies Quarterly report: Q3 2024

Q/C Technologies Proxy statement: Proxy Filing

Nov 1, 2024, 8:00 AM EDT - 1 year ago

Q/C Technologies Proxy statement: Proxy Filing

TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market

Oct 2, 2024, 9:10 AM EDT - 1 year ago

TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market

TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline

Aug 21, 2024, 9:00 AM EDT - 2 years ago

TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline

NiceW2Kid
NiceW2Kid Jun. 24 at 9:49 PM
$QCLS interpretation? I shut down your backpedal with a screenshot What a goddamn fucking piece of shit this stock is that two bulls are arguing about something I mean how the motherfuck cocksuck much longer is these dicksucks going to make us wait???
2 · Reply
NiceW2Kid
NiceW2Kid Jun. 24 at 8:14 PM
$QCLS you're lobbing random bullshit Your prediction about April was 100% wrong and when you tried to backpedal it to regarding short interest I proved you wrong with info anyone can get from nasdaq.com
1 · Reply
henryqoo5779
henryqoo5779 Jun. 24 at 7:46 PM
$QCLS $SPCX suprise me plz
0 · Reply
KKEE122
KKEE122 Jun. 24 at 7:44 PM
$QCLS $SPCX Remember what I mentioned about this stock
0 · Reply
KKEE122
KKEE122 Jun. 24 at 7:21 PM
$QCLS I am watching the World Cup
0 · Reply
KKEE122
KKEE122 Jun. 24 at 7:16 PM
$QCLS Reaching 3.7 is completely natural and genuinely beautiful. This is exactly my entry point now. I’ve already clearly outlined the timeframe and targets for you previously — that’s all we need
0 · Reply
TakingHearts90
TakingHearts90 Jun. 24 at 6:53 PM
$QCLS @KKEE122 is to silent… Abort mission! We are going fishing.
0 · Reply
OnlyFibs
OnlyFibs Jun. 24 at 1:06 AM
Is the market sleeping on $QCLS? 💡 With exclusive global rights to LightSolver’s LPU technology, they’re aiming to disrupt traditional crypto mining with laser-speed, energy-efficient processing. It’s a high-risk "show me" story, but the tech—operating entirely on light—is legitimate deep-tech territory. Patience is the ultimate edge while the company scales this dual-model shift. #QCLS #DeepTech #CryptoMining #hovdid 🐂 Bull Level: A clean hold above $4.00 signals institutional interest is returning. 🐻 Bear Level: Watch $3.75 as the primary pivot; if it snaps, the technical breakdown likely deepens.
0 · Reply
Jj1369
Jj1369 Jun. 23 at 9:02 PM
$QCLS shkreli is a scammer known for pumping stocks he has a position in. Fully expect another large pump here before this tails off into oblivion again. Techinicals are solid. No news since March they gotta have something brewing
0 · Reply
extrodyne
extrodyne Jun. 23 at 7:42 PM
$QCLS "QCLS said Martin Shkreli will add industry connections, early-stage growth expertise, and financial innovation insight as it scales its next-gen computing platform." Yes, yes. A felon advisor. Good strategy.
0 · Reply
Stock_Catcher
Stock_Catcher Jun. 23 at 2:38 PM
Quantum Stocks Swing Trade Angle. Seeing Flow in this Sector Catalysts Coming $ARQQ $INFQ $QTEX $QCLS $QUBT 🤖
0 · Reply
NiceW2Kid
NiceW2Kid Jun. 23 at 2:17 PM
$QCLS curiously green on a red day in the markets and crypto. A few new bulls between here and X. Curious.
1 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Jun. 23 at 2:17 PM
$QCLS About ready to fly.
0 · Reply
Xvool
Xvool Jun. 23 at 2:12 PM
$QCLS 21% is short on a 7 mill float 1.6 million shares ! Squeeze watch
0 · Reply
NiceW2Kid
NiceW2Kid Jun. 23 at 12:39 AM
$QCLS nobody cares. Nothing he's said has lined up with a goddamn, motherfucking, cocksucking thing. I don't care how long he's been on. We've been thru this all before. It's fun when he shows up but not a GD MF CS thing has happened this year.
1 · Reply
TakingHearts90
TakingHearts90 Jun. 22 at 10:28 PM
$QCLS where you at @KKEE122
0 · Reply
stocktwittyrock
stocktwittyrock Jun. 22 at 9:26 PM
$QCLS marty says they have the tech and the means and this just chillin?? Paytienceeee
0 · Reply
Snptrader
Snptrader Jun. 22 at 5:59 PM
$QCLS grabbed a few here..
0 · Reply
Thor1980
Thor1980 Jun. 22 at 5:12 PM
$QCLS come to $TOP an Break 1,50 and fly
1 · Reply
extrodyne
extrodyne Jun. 22 at 3:11 PM
$QCLS The moral of the story is: don't listen to a felon narcissist pump a ticker. Amirite, Martin?
0 · Reply
Xvool
Xvool Jun. 21 at 6:09 PM
$QCLS Trading at $4.02 Martin shkreli is the strategic advisor here and he is saying $100 near term target back in December .. Watching $SPY $NVDA $AAPL
2 · Reply
NiceW2Kid
NiceW2Kid Jun. 21 at 1:33 PM
$QCLS well on the heels of the irregular volume on Thursday's RH close I wish I could say less or none of my shares were borrowed for the long weekend but alas 99.98% were. That has been the amount for the last ten sessions which strikes me as weird; on the first day of said session they were definitely returned, contemplated on and mostly but not 100% borrowed unless someone fat-fingered something. I was 100% borrowed for months straight previously. And then ten sessions went by without the handful left over being scooped up. Is it an AI program or complacent tute? Curious. I mean I'm still convinced it's an institution borrowing them since they have many tricks to extricate themselves from a squeeze (refunds, rewinds, halts, etc) Bro made a comment to someone on X last week that said "I do not control the market! Be patient!" which is heartbreaking because if he's gonna let this happen organically we're going to die holding this. We need tricks. I expect nothing this week.
0 · Reply